Special Interest Group 2021: Neuromuscular Disease (recording)
*This activity is free of charge to those registered for ANA2021. Please click continue to access the content. Please contact us if you are prompted to pay the fee and were registered for the meeting.*
Description: This special interest group session will focus on two areas of contemporary interest in neuromuscular disease. One session will review familial amyloid polyneuropathy and examine the recent development and release of several novel therapies that improve the natural history of this disorder. Another session will review the expanding number of recognized autoantibodies in myositis and discuss the implications for diagnosis and treatment in this heterogeneous group of autoimmune diseases. Three short presentations have been selected from the best accepted neuromuscular abstracts.
Chair: Vern Juel, MD, Duke University
Co-Chair: Michelle Mauermann, MD, Mayo Clinic
Objective(s):
- Recognize the clinical features of familial amyloid polyneuropathy
- Give examples of contemporary treatments for familial amyloid polyneuropathy
- Recognize the limitations of treatments for familial amyloid polyneuropathy
- Identify common myositis autoantibodies
- Describe treatment strategies for distinct autoimmune myopathy syndromes
Presentations:
Therapeutic Advances in Hereditary Transthyretin Amyloid Polyneuropathy
Speaker:
Michelle Mauermann, MD
Mayo Clinic
Myositis Immunology and Autoantibodies
Speaker:
Andrew Mammen, MD, PhD
National Institutes of Health
Neurotoxic Properties of Human Endogenous Retrovirus-k Envelope Protein and Detection in CSF of Patients with ALS
Oral Presenter:
Avindra Nath, MD
National Institutes of Health
Geographical Variation in Proportion of MuSK Antibody Myasthenia Gravis Around the World – A Multicenter Study
Oral Presenter:
Angela Vincent, MBBS
University of Oxford
NADPH Oxidase 5: A New Player in Peripheral Neuropathy
Oral Presenter:
Stephanie Eid, PhD
University of Michigan
Target Audience
ANA2021 Attendees
Please visit https://2021.myana.org/sig-series for details.
Available Credit
- 1.50 AMA PRA Category 1 Credit™The American Neurological Association is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The American Neurological Association designates this Enduring material for a maximum of 1.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 1.50 Participation